174 related articles for article (PubMed ID: 27267189)
1. Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation.
Eichenfield DZ; Cohen PR
Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267189
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic antidepressant-induced photosensitivity; A case report and systematic review.
Boontaveeyuwat E; Steyn M; Rickaby W; Mcfadden JP; Sarkany RPE; Fityan A
Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):112-122. PubMed ID: 34358364
[TBL] [Abstract][Full Text] [Related]
3. Imipramine-induced hyperpigmentation: four cases and a review of the literature.
Ming ME; Bhawan J; Stefanato CM; McCalmont TH; Cohen LM
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):159-66. PubMed ID: 10025739
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity syndrome caused by amitriptyline administration.
Milionis HJ; Skopelitou A; Elisaf MS
Postgrad Med J; 2000 Jun; 76(896):361-3. PubMed ID: 10824052
[TBL] [Abstract][Full Text] [Related]
5. Laser treatment of imipramine-induced hyperpigmentation.
Atkin DH; Fitzpatrick RE
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):77-80. PubMed ID: 10863228
[TBL] [Abstract][Full Text] [Related]
6. Photodistributed blue-gray pigmentation of the skin associated with long-term imipramine use.
Angel TA; Stalkup JR; Hsu S
Int J Dermatol; 2002 Jun; 41(6):327-9. PubMed ID: 12100685
[TBL] [Abstract][Full Text] [Related]
7. Imipramine-induced facial pigmentation: case report and literature review.
Metelitsa AI; Nguyen GK; Lin AN
J Cutan Med Surg; 2005 Dec; 9(6):341-5. PubMed ID: 17016757
[TBL] [Abstract][Full Text] [Related]
8. Novel hyperpigmentation pathophysiology following a prolonged course of imipramine therapy.
McKenna B; Wold L; Noland MM; Schenck O
J Cutan Pathol; 2024 Feb; 51(2):105-107. PubMed ID: 37818708
[TBL] [Abstract][Full Text] [Related]
9. Imipramine-induced hyperpigmentation: a case report and review of the literature.
D'Agostino ML; Risser J; Robinson-Bostom L
J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613
[TBL] [Abstract][Full Text] [Related]
10. Imipramine-Induced Cutaneous and Iris Hyperpigmentation: A Case Report and Literature Review.
Coffey N; Ali Z; Grau J
Prim Care Companion CNS Disord; 2022 Mar; 24(2):. PubMed ID: 35364629
[No Abstract] [Full Text] [Related]
11. Imipramine-induced hyperpigmentation.
Bicknell LM; McFaddin CL; Fernandez M; Parekh P
Cutis; 2017 Sep; 100(3):E8-E10. PubMed ID: 29121138
[TBL] [Abstract][Full Text] [Related]
12. Imipramine-induced hyperpigmentation of the skin.
Mehr N; Wu JJ; Dyson SW; Woseth DM
Dermatol Online J; 2007 Oct; 13(4):8. PubMed ID: 18319005
[No Abstract] [Full Text] [Related]
13. Desipramine-induced blue-gray photosensitive pigmentation.
Narurkar V; Smoller BR; Hu CH; Bauer EA
Arch Dermatol; 1993 Apr; 129(4):474-6. PubMed ID: 8466219
[TBL] [Abstract][Full Text] [Related]
14. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.
Izikson L; Anderson RR
Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303
[No Abstract] [Full Text] [Related]
15. Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence.
Böhm M; Schmidt PF; Lödding B; Uphoff H; Westermann G; Luger TA; Bonsmann G; Metze D
Am J Dermatopathol; 2002 Aug; 24(4):345-50. PubMed ID: 12142617
[TBL] [Abstract][Full Text] [Related]
16. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of psychotropic drug-induced facial hyperpigmentation with a 755-nm Q-switched alexandrite laser.
Wee SA; Dover JS
Dermatol Surg; 2008 Nov; 34(11):1609-12. PubMed ID: 19021670
[No Abstract] [Full Text] [Related]
18. Imipramine monotherapy-induced Hyperpigmentation in an adolescent girl.
Mendhekar DN
Indian J Med Sci; 2005 Sep; 59(9):405-6. PubMed ID: 16199927
[No Abstract] [Full Text] [Related]
19. Inhibited female orgasm resulting from psychotropic drugs. A five-year, updated, clinical review.
Shen WW; Sata LS
J Reprod Med; 1990 Jan; 35(1):11-4. PubMed ID: 2405155
[TBL] [Abstract][Full Text] [Related]
20. [Skin pigmentation induced by meropenem and levofloxacin].
Garval E; Vuiblet V; Durlach A; Perceau G; Anuset D; Bernard P
Ann Dermatol Venereol; 2017 Dec; 144(12):793-798. PubMed ID: 29031417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
